Professor Hans Langendijk graduated from the Free University School of Medicine in Amsterdam in 1989. He completed his residency in Radiation Oncology at the Radiotherapeutic Institute in Heerlen and Maastricht (now MAASTRO) in 1997. In 2000, he earned his PhD from the University of Maastricht with a thesis titled “Quality of Life in Non-small Cell Lung Cancer.”
From 1997 to 2004, he worked in the Department of Radiation Oncology at VU University Medical Center, where he specialized in head and neck radiation oncology. Since October 2004, he has served as Professor and Chair of the Department of Radiation Oncology at the University Medical Center Groningen. His research focuses on head and neck oncology, the prediction, prevention, and treatment of radiation-induced side effects, and the development and validation of new radiation techniques, such as proton therapy. As of April 2023, he holds the position of Chair of the Oncology Division at the University Medical Center Groningen.
Professor Langendijk has initiated and coordinated numerous multicenter clinical trials and has authored or co-authored over 560 papers and book chapters, primarily in the fields of head and neck oncology, radiation-induced side effects, and proton therapy. He also leads a work package within the European Proton Therapy Network (EPTN), fostering national and international collaborations to create prospective data registries. He is the founder of the model-based approach used in the Netherlands for selecting patients for proton therapy based on evidence-based criteria.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none